Neuropathological changes induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in male Swiss albino mice

Toxicology and Industrial Health

Volumn 24, Issue 3, 2008, Pages 189-194

  Rajeswari, A ^a   Sabesan, M ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

cat; dopamine; GSH; MPTP; SOD; ultra structure

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIOXIDANT; DOPAMINE; CATALASE; GLUTATHIONE; NEUROTOXIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DYSTONIA; HINDLIMB; INFUSION; INTOXICATION; MALE; METABOLISM; MITOCHONDRION; MOUSE; OXIDATIVE STRESS; PATHOLOGY; ULTRASTRUCTURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN MITOCHONDRION; CELL NUCLEUS MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; MESENCEPHALON; MOUSE STRAIN; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PROTEIN DEPLETION; TRANSMISSION ELECTRON MICROSCOPY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIOXIDANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; HINDLIMB; INFUSIONS, PARENTERAL; MALE; MICE; MITOCHONDRIA; MPTP POISONING; OXIDATIVE STRESS;

MUS;

EID: 59649083002     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233708093726     Document Type: Article

References (19)

1. Baba M, Takeshige K, Bala N, Ohsumi Y (1994) Ultrastrutural analysis of the autophagic process in yeast : deliction of autophagosome and this characterization. J Cell Biol 124: 903–913.
2. Baum RM; (1985) New variety of street drugs poses growing prolong. Chem Eng 7: 7–16.
3. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70–77.
4. Hallman H; Lange J; Olson L; Stromberg I; Jonsson G; (1985) Neurochemical and histochemical charcterisation of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain calicholamine. J Neurochem 44: 117–127.
5. Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224: 1451–1453.
6. Irwin I, Langston JW (1985) Selective accumulation of MPP+ in the Substantia nigra : a key to Neurotoxicity. Life Sci 36: 207–212.
7. Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21: 130–132.
8. Langston JW (1985a) MPTP and Parkinson's disease. Trends Neurosci 8: 79–83.
9. Langston JW (1985b) MPTO neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 36: 201–206.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1954) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–275.
11. Nichans WG, Samuelson D (1968) Formation of malonaldehyde from pospholipid arrachidonate during microsomal lipid peroxidation. Eur J Biochem 6: 126–130.
12. Poirier J, Barbeau A (1985) A catalyst function for MPTP in superoxide formation. Biochem Biophys Res Commun 131: 1284–1289.
13. Poirier J, Dea D, Baccichet A, Thiffault C (1994) Superoxide dismutase expression in Parkinson's diseases. Ann N Y Acad Sci 738: 116–120.
14. Ramsay RR, Kruger MJ, Youngster SK, Gluck MR, Casida JE, Singer TP (1991) Interaction of n methyl-4 phenyl pyridinium ion (MMP+) and its analogs with the eotenone/piericidin binding site of NADH dehydro genase. J Neurochem 56: 1184–1190.
15. Sian J, Dexli DT, Less AJ (1994) Alliations in glutathione levels in Parkinson's disease and other neurodegenate discovers affecting basal ganglia. Ann New 36: 348–355.
16. Singer TP, Ramsay RR, McKeown K, Trevor A, Castagnoli A (1988) Mechanism of neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1 methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49: 17–23.
17. Sinha KA (1972) Colorimetric assay of catalase. Anal Biochem 47: 389–394.
18. Song DD, Shults CW, Sisk A, Rockensteim E, Masliach E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuckin transgenic mice after treatment with MPTP. Exp Neurol 186: 158–172.
19. Tanji H, Araki T, Nagasawa H, Itoyama Y (1999) Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Brain Res 824: 224–231.